Webinar: Get To The Bottom of Your Gut

Key Learning Objectives

• What is the best method of sample preparation to maintain RNA integrity for liquid biopsy samples?
• What is the expected yield of RNA from various liquid biopsy samples?
• What is the best method of quantification for ultra-low RNA concentrations?
• How can I maximize RNA concentration for downstream applications, such as NGS?
• What is the difference between RNA-seq and small RNA-seq, and which one should I use with my liquid biopsy samples?

Abstract:
Join our expert panel of scientists in this Live Q&A session to explore all of the complexities of processing and analyzing of RNA from liquid biopsy samples. Liquid biopsy samples are increasingly becoming one of the most valuable, minimally-invasive sources of information as the basis of diagnosis and disease monitoring as well as disease prevention. Biospecimens such as plasma, serum and urine contain various biomarkers that provide key insights into changes within the genome, epigenome, transcriptome and proteome of a patient. In this webinar, we'll answer all of your RNA questions related to biological specimen handling, RNA purification, quantification and downstream applications, including qRT-PCR and Next Generation Sequencing.

Speakers: 
Dr. Patricia Barbalho, PhD, is the most recent addition to Norgen's ever growing Research &Development Team.
With a PhD in medical genetics, she currently works as a Research Scientistoverseeing of the testing and validation of Norgen's product portfolio including nucleic acidpurification kits, MDx assays as well biospecimen collection devices for regulatory submissionfor in vitro diagnostics. Dr. Barbalho plays an instrumental role in achieving regulatorycertifications from international bodies for Norgen's product line including CE marking, HealthCanada and the FDA.

Dr. Alex Chauhan, PhD, is a Research Scientist on Norgen's Next Generation Sequencing ServicesTeam.
With a PhD in applied sciences and cancer biology, Dr. Chauhan has extensive expertiseworking with liquid biopsy samples of all types. He oversees all client NGS projects, andspecifically works with Small RNA-Sequencing for challenging ultra-low input sample types, suchas cerebral spinal fluid and plasma/serum. In addition to his contributions to the NGS team, Dr.Chauhan holds a valuable role in Research and Development for Norgen's line of cell-free RNAand cell-free DNA purification kits.

When: Thursday, 18 August, 2022 at 16:30 CET

Where: Online (free)